Shareholder Votes

COGNIZANT TECHNOLOGY SOLUTIONS CORP shareholders approved Ratification of Appointment of Independent Registered Public Accounting Firm at the 2026-06-02 meeting.

“Proposal 3. Ratification of Appointment of Independent Registered Public Accounting Firm The vote with respect to the ratification of PricewaterhouseCoopers LLP as the Company’s independent registered public accounting firm for the year ending December 31, 2026 was as follows: For Against Abstain Broker Non-Votes 398,861,120 41,096,195 283,600 -”

COGNIZANT TECHNOLOGY SOLUTIONS CORP shareholders approved Advisory Vote to Approve Executive Compensation (Say-on-Pay) at the 2026-06-02 meeting.

“Proposal 2. Advisory Vote to Approve Executive Compensation (Say-on-Pay) The advisory vote on the compensation of the Company’s named executive officers was as follows: For Against Abstain Broker Non-Votes 387,762,676 28,276,341 869,351 23,332,547”

COGNIZANT TECHNOLOGY SOLUTIONS CORP shareholders approved Election of 13 Director Nominees at the 2026-06-02 meeting.

“At the Annual Meeting, all of the directors were re-elected”

Robinhood Markets, Inc. shareholders approved Ratification of Appointment of Independent Registered Public Accounting Firm at the 2026-06-02 meeting.

“Our stockholders ratified the appointment of Ernst & Young LLP (“EY”) as the Company’s independent registered public accounting firm for the fiscal year ending December 31, 2026.”

Robinhood Markets, Inc. shareholders approved Advisory Vote to Approve the Compensation of Our Named Executive Officers at the 2026-06-02 meeting.

“Our stockholders approved, on an advisory basis, the 2025 compensation of the Company’s named executive officers.”

Robinhood Markets, Inc. shareholders approved Election of Directors at the 2026-06-02 meeting.

“Our stockholders re-elected Vladimir Tenev, Baiju Bhatt, John Hegeman, Paula Loop, Meyer Malka, Christopher Payne, Jonathan Rubinstein, Susan Segal, Dara Treseder, and Robert Zoellick to the Company’s Board of Directors to serve until the 2027 annual meeting of stockholders.”

Vireo Growth Inc. shareholders approved To consider and, if thought appropriate, to pass an ordinary resolution approving a distribution of securities to Mr. Mazarakis in accordance with the Second Amendment to the Mazarakis Employment Agreement, the full text of which is set forth in Proposal 6 in the Circular. at the 2026-05-29 meeting.

“Proposal #6 To consider and, if thought appropriate, to pass an ordinary resolution approving a distribution of securities to Mr. Mazarakis in accordance with the Second Amendment to the Mazarakis Employment Agreement, the full text of which is set forth in Proposal 6 in the Circular. For Against Abstentions Broker Non-Votes 459,058,140 19,155,087 94,909,458 58,675,720”

Vireo Growth Inc. shareholders approved To consider and, if thought appropriate, to pass an ordinary resolution approving a Second Amendment to the Employment Agreement between the Company and John Mazarakis as the Chief Executive Officer of the Company (the “Second Amendment to the Mazarakis Employment Agreement”), as more fully describe at the 2026-05-29 meeting.

“Proposal #5 To consider and, if thought appropriate, to pass an ordinary resolution approving a Second Amendment to the Employment Agreement between the Company and John Mazarakis as the Chief Executive Officer of the Company (the “Second Amendment to the Mazarakis Employment Agreement”), as more fully described in the Circular. For Against Abstentions Broker Non-Votes 446,824,793 31,397,846 94,900,046 58,675,720”

Vireo Growth Inc. shareholders approved To appoint Davidson & Company LLP as the auditors of the Company for the ensuing year and to authorize the Board to fix their remuneration. at the 2026-05-29 meeting.

“Proposal #4 To appoint Davidson & Company LLP as the auditors of the Company for the ensuing year and to authorize the Board to fix their remuneration. For Against Abstentions Broker Non-Votes 631,071,841 691,843 34,721 —”

Vireo Growth Inc. shareholders approved To consider and, if thought appropriate, to pass an ordinary resolution approving a consolidation of the Company’s outstanding subordinate voting shares, multiple voting shares and the super voting shares, each without par value, at a ratio not less than 20-for-1 and not more than 40-for-1, with the at the 2026-05-29 meeting.

“Proposal #3 To consider and, if thought appropriate, to pass an ordinary resolution approving a consolidation of the Company’s outstanding subordinate voting shares, multiple voting shares and the super voting shares, each without par value, at a ratio not less than 20-for-1 and not more than 40-for-1, with the ratio at which the consolidation would be effected to be a ratio within the range to be determined at the discretion of the board of directors of the Company (the “Board”), the full text of which is set forth in Proposal 3 in the Circular. For Against Abstentions Broker Non-Votes 622,771,167 1,013,130 8,014,108 —”

Vireo Growth Inc. shareholders approved To elect Dr. Kyle E. Kingsley, Ross M. Hussey, Victor E. Mancebo, Judd T. Nordquist, John Mazarakis, Michael Steiner and Christopher J. Hagedorn as directors of the Company to take office immediately following the Annual Meeting. at the 2026-05-29 meeting.

“Proposal #2 To elect Dr. Kyle E. Kingsley, Ross M. Hussey, Victor E. Mancebo, Judd T. Nordquist, John Mazarakis, Michael Steiner and Christopher J. Hagedorn as directors of the Company to take office immediately following the Annual Meeting.”

Vireo Growth Inc. shareholders approved To fix the number of directors of the Company to be elected at seven. at the 2026-05-29 meeting.

“Proposal #1 To fix the number of directors of the Company to be elected at seven. For Against Abstentions Broker Non-Votes 631,224,603 473,650 100,152 —”

DOCUSIGN, INC. shareholders rejected Stockholder proposal to report on risks of non-fiduciary executive compensation metrics at the 2026-06-01 meeting.

“Proposal Five - Stockholder Proposal to Report on Risks of Non-Fiduciary Executive Compensation Metrics The Company’s stockholders did not approve a stockholder proposal to report on the risks of non-fiduciary executive compensation metrics, based on the following voting results: Votes For Votes Against Abstentions Broker Non-Votes 1,798,025 135,574,518 875,053 30,922,049”

DOCUSIGN, INC. shareholders approved Advisory vote on frequency of future non-binding votes on named executive officer compensation at the 2026-06-01 meeting.

“Proposal Four - Advisory Vote on the Frequency of Future Non-Binding Votes on Our Named Executive Officers’ Compensation On a non-binding advisory basis, the Company’s stockholders approved a frequency of one year of future non-binding votes on the compensation of the Company’s named executive officers, based on the following voting results: 1 Year 2 Years 3 Years Abstentions 135,796,834 40,638 2,242,697 167,427”

DOCUSIGN, INC. shareholders approved Advisory vote on compensation of named executive officers for fiscal year ended January 31, 2026 at the 2026-06-01 meeting.

“Proposal Three - Advisory Vote on Our Named Executive Officers' Compensation On a non-binding advisory basis, the Company’s stockholders approved the compensation of the Company’s named executive officers for the fiscal year ended January 31, 2026, based on the following voting results: Votes For Votes Against Abstentions Broker Non-Votes 120,123,414 17,542,650 581,532 30,922,049”

DOCUSIGN, INC. shareholders approved Ratification of appointment of PricewaterhouseCoopers LLP as independent registered accounting firm for fiscal year ending January 31, 2027 at the 2026-06-01 meeting.

“Proposal Two - Ratification of Selection of Independent Public Registered Accounting Firm The Company’s stockholders ratified the appointment of PricewaterhouseCoopers LLP as the Company’s independent registered accounting firm for the fiscal year ending January 31, 2027, by the following votes: Votes For Votes Against Abstentions 166,765,670 2,050,457 353,518”

DOCUSIGN, INC. shareholders approved Election of three directors to serve until the 2029 Annual Meeting at the 2026-06-01 meeting.

“Proposal One - Election of Directors The Company’s stockhol ders approved the election of three directors, each to serve for a three-year term expiring at the 2029 Annual Meeting of Stockholders and until such director’s successor is elected and qualified, by the following votes: Nominee Votes For Votes Against Abstentions Broker Non-Votes James Beer 99,165,135 38,858,327 224,134 30,922,049 Cain A. Hayes 100,373,130 37,649,089 225,377 30,922,049 Allan Thygesen 107,151,954 30,912,715 182,927 30,922,049”

InspireMD, Inc. shareholders approved Ratification of Auditors at the 2026-06-03 meeting.

“Proposal No. 3 - Ratification of Auditors. The stockholders ratified the appointment of Kesselman & Kesselman, a member of PricewaterhouseCoopers International Limited, as the Company’s independent registered public accounting firm for the 2026 fiscal year. The votes were as follows: For Against Abstain 34,355,150 244,248 31,950”

InspireMD, Inc. shareholders approved Increase in Authorized Shares at the 2026-06-03 meeting.

“Proposal No. 2 – Increase in Authorized Shares. The stockholders approved an amendment to the Company’s Amended and Restated Certificate of Incorporation to increase the authorized number of shares of the Company’s common stock from 150,000,000 shares to 250,000,000 shares. The votes were as follows: For Against Withheld Broker Non-Votes 31,577,297 3,009,107 44,944 0”

InspireMD, Inc. shareholders approved Election of Directors at the 2026-06-03 meeting.

“Proposal No. 1 - Election of Directors. The stockholders re-elected Marvin Slosman, Raymond Cohen and Dan Dearen to serve on the board of directors of the Company, as Class 3 directors, for a term of three years or until their respective successor is elected and qualified. The votes were as follows: Director Name For Withheld Broker Non-Votes Marvin Slosman 25,086,284 1,728,950 7,816,114 Raymond Cohen 22,733,263 4,081,971 7,816,114 Dan Dearen 22,750,906 4,064,328 7,816,114”

Shimmick Corp shareholders approved Ratification of Appointment of Independent Registered Public Accounting Firm at the 2026-06-02 meeting.

“Proposal 2 - Ratification of Appointment of Independent Registered Public Accounting Firm The Company’s stockholders ratified the appointment of Deloitte & Touche LLP as the Company’s independent registered public accounting firm for the fiscal year ending January 1, 2027.”

Shimmick Corp shareholders approved Election of Directors at the 2026-06-02 meeting.

“Proposal 1 - Election of Directors The Company’s stockholders elected the persons listed below as directors for one-year terms expiring at the Company’s 2027 Annual Meeting of Stockholders and until his successor is elected.”

BARRETT BUSINESS SERVICES INC shareholders approved Ratification of the selection of Deloitte and Touche LLP as the Company's independent registered public accounting firm for the year ending December 31, 2026 at the 2026-06-01 meeting.

“Ratification of the selection of Deloitte and Touche LLP as the Company's independent registered public accounting firm for the year ending December 31, 2026.”

BARRETT BUSINESS SERVICES INC shareholders approved Approval, by non-binding, advisory vote, of the compensation paid to the Company's named executive officers at the 2026-06-01 meeting.

“Approval, by non-binding, advisory vote, of the compensation paid to the Company's named executive officers.”

BARRETT BUSINESS SERVICES INC shareholders approved Approval of the Barrett Business Services, Inc. Second Amended and Restated 2020 Stock Incentive Plan at the 2026-06-01 meeting.

“Approval of the Barrett Business Services, Inc. Second Amended and Restated 2020 Stock Incentive Plan.”

BARRETT BUSINESS SERVICES INC shareholders approved Election of nine directors for a one-year term until the 2027 annual meeting at the 2026-06-01 meeting.

“Nine directors were elected, each for a one-year term to serve until the 2027 annual meeting of stockholders, by the votes indicated.”

Xenon Pharmaceuticals Inc. shareholders approved Proposal Six – Remuneration of Auditor at the 2026-06-02 meeting.

“Proposal Six – Remuneration of Auditor. The authority of the audit committee of the Board to set the remuneration of the auditor for the ensuing year was approved as follows: For Against Abstain Broker Non-Votes 90,370,029.64 2,369.65 27,237.00 0.00”

Xenon Pharmaceuticals Inc. shareholders approved Proposal Five – Appointment of Auditor at the 2026-06-02 meeting.

“Proposal Five – Appointment of Auditor. The appointment of PricewaterhouseCoopers LLP as the Company’s independent registered public accounting firm for the ensuing year was approved as follows: For Withheld Broker Non-Votes 90,371,967.64 27,668.65 0.00”

Xenon Pharmaceuticals Inc. shareholders approved Proposal Four – 2026 Equity Incentive Plan at the 2026-06-02 meeting.

“Proposal Four – 2026 Equity Incentive Plan. The Company's 2026 Equity Incentive Plan was approved as follows: For Against Abstain Broker Non-Votes 58,579,810.00 27,570,443.18 842,250.00 3,407,133.11”

Xenon Pharmaceuticals Inc. shareholders approved Proposal Three – Advisory Vote on Frequency of Say-on-Pay at the 2026-06-02 meeting.

“Proposal Three – Advisory Vote on Frequency of Say-on-Pay. The frequency of advisory votes on the compensation of the Company’s named executive officers, on an advisory basis, was approved as follows: 1 Year 2 Year 3 Year Abstain Broker Non-Votes 86,918,084.18 2,360.00 43,281.00 28,778.00 3,407,133.11”

Xenon Pharmaceuticals Inc. shareholders approved Proposal Two – Advisory Vote on Compensation of Named Executive Officers ("Say-on-Pay") at the 2026-06-02 meeting.

“Proposal Two – Advisory Vote on Compensation of Named Executive Officers (“Say-on-Pay”). The compensation of the Company’s named executive officers, on an advisory basis, was approved as follows: For Against Abstain Broker Non-Votes 82,156,320.53 4,769,025.65 67,157.00 3,407,133.11”

Xenon Pharmaceuticals Inc. shareholders approved Proposal One – Election of Directors at the 2026-06-02 meeting.

“Proposal One – Election of Directors . The following nominees were elected as directors to serve until the 2027 annual meeting of shareholders or until their respective successors are duly elected and qualified: For Against Broker Non-Votes Dawn Svoronos 82,475,281.53 4,517,221.65 3,407,133.11 Gillian Cannon 84,844,120.53 2,148,382.65 3,407,133.11 Steven Gannon 86,149,107.53 843,395.65 3,407,133.11 Elizabeth Garofalo 84,808,573.53 2,183,929.65 3,407,133.11 Justin Gover 86,290,281.53 702,221.65 3,407,133.11 Patrick Machado 86,603,916.53 388,586.65 3,407,133.11 Ian Mortimer 86,524,582.53 467,920.65 3,407,133.11 Gary Patou 86,114,511.53 877,991.65 3,407,133.11”

Inhibrx Biosciences, Inc. shareholders approved Ratification of the appointment by the Audit Committee of the Board of Directors of BDO USA, P.C. as the Company’s independent registered public accounting firm for the fiscal year ending December 31, 2026. at the 2026-06-03 meeting.

“Proposal 2 Ratification of the appointment by the Audit Committee of the Board of Directors of BDO USA, P.C. as the Company’s independent registered public accounting firm for the fiscal year ending December 31, 2026. Votes For Votes Against Votes Abstained 11,510,478 30,347 407”

Inhibrx Biosciences, Inc. shareholders approved Election of the following nominees as Class II directors of the Company at the 2026-06-03 meeting.

“Proposal 1 Election of the following nominees as Class II directors of the Company, nominated by the Company’s Board of Directors (the “Board of Directors”), each to serve until the 2029 Annual Meeting of Stockholders and until their respective successor is duly elected and qualified, or until their respective earlier death, resignation, or removal. Votes For Votes Withheld Broker Non-Votes Douglas G. Forsyth 7,608,469 1,463,474 2,469,289 Kimberly Manhard 9,035,097 36,846 2,469,289”

Amplify Energy Corp. shareholders approved Approval, by a Non-Binding Vote, of the Frequency of Future Advisory Votes on Executive Compensation at the 2026-06-03 meeting.

“The frequency of advisory votes on compensation of the Company’s named executive officers to occur every year was approved, by a non-binding vote, as follows: Every Year Every Two Years Every Three Years Abstain 14,350,709 27,050 1,607,544 44,848”

Amplify Energy Corp. shareholders approved Approval of the Amplify Energy Corp. 2024 Amended and Restated Equity Incentive Plan at the 2026-06-03 meeting.

“The Amplify Corp. 2024 Amended and Restated Equity Incentive Plan was approved, as follows: For Against Abstain Broker-Non-Votes 14,749,115 1,094,838 186,198 10,563,307”

Amplify Energy Corp. shareholders approved Approval of the Compensation, on a Non-Binding Advisory Basis, of the Company’s Named Executive Officers at the 2026-06-03 meeting.

“The compensation of the Company’s named executive officers was approved, on a non-binding advisory basis, as follows: For Against Abstain Broker-Non-Votes 14,823,670 1,050,237 156,244 10,563,307”

Amplify Energy Corp. shareholders approved Ratification of the Appointment of Grant Thornton LLP as Independent Registered Public Accounting Firm at the 2026-06-03 meeting.

“The appointment of Grant Thornton LLP as the Company’s independent registered public accounting firm for 2026 was ratified.”

Amplify Energy Corp. shareholders approved Election of five directors at the 2026-06-03 meeting.

“Deborah G. Adams, Clint Coghill, Daniel Furbee, Christopher W. Hamm and Todd R. Snyder were elected to continue to serve as the Company’s directors until the 2027 Annual Meeting of Stockholders or until their respective successors are duly elected and qualified.”

Keros Therapeutics, Inc. shareholders approved Advisory vote on executive compensation. at the 2026-06-03 meeting.

“The Company’s stockholders approved, on a non-binding advisory basis, Proposal 3. The votes cast were as follows: Votes For Votes Against Votes Abstain Broker Non-Votes 14,273,625.27 974,049 2,038 2,243,514”

Keros Therapeutics, Inc. shareholders approved Ratification of the selection of Deloitte & Touche LLP as the independent registered public accounting firm for fiscal year ending December 31, 2026. at the 2026-06-03 meeting.

“The Company’s stockholders approved Proposal 2. The votes cast were as follows: Votes For Votes Against Votes Abstain 16,708,279.27 783,953 994 There were no broker non-votes with respect to Proposal 2.”

Keros Therapeutics, Inc. shareholders approved Election of two nominees for director to hold office until the Company's 2029 Annual Meeting of Stockholders and until their successors are duly elected and qualified. at the 2026-06-03 meeting.

“The Company’s stockholders elected the two persons listed below as directors, each to serve until the Company’s 2029 Annual Meeting of Stockholders and until their respective successors are duly elected and qualified. The votes cast were as follows: Nominee Votes For Votes Withheld Broker Non-Votes Jean-Jacques Bienaimé 10,093,559.27 5,156,153 2,243,514 Charles Newton 14,716,598 533,114 2,243,514”

WATSCO INC shareholders approved Ratification of the appointment of Deloitte & Touche LLP as the Company’s independent registered public accounting firm for the 2026 fiscal year at the 2026-06-01 meeting.

“Proposal 3. Ratification of the appointment of Deloitte & Touche LLP as the Company’s independent registered public accounting firm for the 2026 fiscal year. The combined vote of the Company’s Common and Class B common stock was as follows: Votes For Votes Against Abstentions Broker Non-Votes 86,731,800 9,111 64,545 -”

WATSCO INC shareholders approved Approval of a non-binding advisory resolution regarding the compensation of the Company’s named executive officers at the 2026-06-01 meeting.

“Proposal 2. Approval of a non-binding advisory resolution regarding the compensation of the Company’s named executive officers. The combined vote of the Company’s Common and Class B common stock was as follows: Votes For Votes Against Abstentions Broker Non-Votes 80,839,936 2,969,397 125,790 2,870,337”

WATSCO INC shareholders approved Election of Directors at the 2026-06-01 meeting.

“Proposal 1. As set forth in the table that follows, (1) election of one director to serve as a Common stock director by Common shareholders voting as a single class and (2) election of two Class B Common stock directors by Class B common shareholders voting as a single class: Nominee Term Expires Votes For Votes Against Abstentions Broker Non-Votes Common Stock: Ana Lopez-Blazquez 2029 24,485,246 6,076,578 17,619 1,629,623 Class B Common Stock: Cesar L. Alvarez 2029 53,231,431 111,874 12,375 1,240,714 Denise Dickins 2029 53,242,653 113,027 - 1,240,714”

Kingfish Holding Corp shareholders approved Ratification of Independent Auditors at the 2026-06-01 meeting.

“Proposal 2 – Ratification of Independent Auditors Votes Cast For Approval: 771,497 100% of the votes cast, representing 91.5% of outstanding shares Votes Cast Against Approval: 0 0% Abstentions: 0 0%”

Kingfish Holding Corp shareholders approved Election of Directors at the 2026-06-01 meeting.

“Nominees Votes For % For Votes Against % Against Abstentions James LaManna 771,497 100 0 0 0 James R. Lindsay 771,497 100 0 0 0 Lisa Matthews 771,497 100 0 0 0 Keri A. Moritz 771,497 100 0 0 0 Randall A. Moritz 771,497 100 0 0 0 Ted Sparling 771,497 100 0 0 0 Lori M. Toomey 771,497 100 0 0 0 James K. Toomey 771,497 100 0 0 0”

Hoyne Bancorp, Inc. shareholders approved Ratification of the appointment of Wipfli LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2026 at the 2026-05-28 meeting.

“PROPOSAL 2: Ratify Appointment of Wipfli LLP . The ratification of the appointment of Wipfli LLP as the Company’s independent registered public accounting firm for the fiscal year ending December 31, 2026: FOR AGAINST ABSTAIN BROKER NON-VOTES 5,574,944 180,467 274,028 -”

Hoyne Bancorp, Inc. shareholders approved Election of three director nominees to serve for a term of three years expiring at the Company's 2029 Annual Meeting at the 2026-05-28 meeting.

“The final results of the stockholder vote on each of the proposals presented at the meeting are as follows: PROPOSAL 1: Election of Directors . The election of three (3) director nominees to each serve for a term of three years expiring at the Company’s 2029 Annual Meeting, or until their successors are duly elected and qualified: Name of Director Nominee FOR WITHHELD BROKER NON-VOTES David M. Opas 3,854,863 425,958 1,748,618 Janet H. Winningham 3,915,209 365,612 1,748,618 Anthony M. Vaccarello 3,852,193 428,628 1,748,618”

ZION OIL & GAS INC shareholders approved Approve, in a nonbinding advisory vote, the frequency of future nonbinding advisory votes on the compensation of the Company’s Named Executive Officers at the 2026-06-02 meeting.

“The Company’s common stockholders approved 3 years as the frequency of shareholder nonbinding advisory votes on the compensation of its named executive officers as stated in the number of votes cast for each of 1 year, 2 years, and 3 years, as well as the number of abstentions as set forth below:”